|
Jul 29
|
5 Stocks With Recent Price Strength to Maximize Your Gains
|
|
Jul 28
|
Here is Why Growth Investors Should Buy Orion OYJ (ORINY) Now
|
|
Jul 28
|
Orion OYJ (ORINY) is on the Move, Here's Why the Trend Could be Sustainable
|
|
Jul 21
|
Darolutamide receives EU approval in third indication for patients with advanced prostate cancer
|
|
Jul 18
|
Orion Group Half-Year Financial Report January–June 2025
|
|
Jul 18
|
Orion Corporation’s financial reporting and Annual General Meeting in 2026
|
|
Jun 23
|
141,959 Orion Corporation A shares converted into B shares
|
|
Jun 20
|
CHMP recommends third indication for darolutamide for patients with advanced prostate cancer
|
|
Jun 17
|
Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
|
|
Apr 10
|
The Helsinki Court of Appeal sentenced a member of Orion's Board of Directors to a fine for a securities market information offence
|
|
Apr 9
|
Orion publishes Interim Report for January–March 2025 and holds a webcast on 23 April 2025
|
|
Jan 2
|
3 Leading Dividend Stocks Yielding Up To 8.5%
|
|
Dec 30
|
Orion and Marinus terminate agreement for ganaxolone in Europe
|
|
Jul 25
|
Orion publishes Half-Year Financial Report for January–June 2024 and holds a webcast on 8 August 2024
|
|
Feb 19
|
Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland
|
|
Jan 11
|
Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2024 Annual General Meeting
|
|
Jan 11
|
Insurance portfolio of Orion Pension Fund’s B fund transferred to an external pension insurance company – the transfer has approximately EUR 31 million positive impact on Orion’s result in 2023
|
|
Dec 4
|
87 000 Orion Corporation A shares converted into B shares
|
|
Oct 26
|
Orion Group Interim Report January–September 2023
|
|
Sep 20
|
Change in Orion Group's Half-Year Financial Report 2024 publication date
|